Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  Sensus Gains China Approval of Radiation Device for Keloids
  WuXi AppTec Participates in $5.9 Million Series A for Rodeo Therapeutics
  Nanjing Frontier Acquires Rights to Rockefeller University HIV/AIDS Antibody
  DelMar Approved to Start China Phase II Trial of Brain Cancer Treatment
  Geneseeq Raises "Hundred of Millions of RMB" in C Round to Develop NGS
  Cardinal Health Plans $1.5 Billion Sale of China Drug Distribution Business
  Beijing's Symbow Closes $17 Million Funding for Surgical Navigator
  Uni-Bio Raises $18.2 Million; Partners with HeungKong Group
  iKang Forms $74 Million Partnership for New China Healthcare Clinics
  China Adds 36 Drugs to NDRL Following Major Price Cuts
 
Login